Morning Seminar July 2, 2009

N Engl J Med. 2009 Jun 25;360(26):2730-41.
Treating childhood acute lymphoblastic leukemia without cranial irradiation.Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV.

Morning Seminar June 30, 2009

Nature. 2009 Jun 25;459(7250):1126-30.
Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, Ryeom S.

Morning Seminar June 25, 2009

N Engl J Med. 2004 Sep 16;351(12):1175-86.
Talking about death with children who have severe malignant disease.
Kreicbergs U, Valdimarsdóttir U, Onelöv E, Henter JI, Steineck G.

Morning Seminar June 23, 2009

Blood. 2009 Jan 22;113(4):775-83.
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
Montesinos P, Bergua JM, Vellenga E, Rayón C, Parody R, de la Serna J, León A, Esteve J, Milone G, Debén G, Rivas C, González M, Tormo M, Díaz-Mediavilla J, González JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA.

Morning Seminar June 18, 2009

Bone Marrow Transplant. 2009 Mar;43(5):351-6.
Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice.
Battiwalla M, McCarthy PL.

Morning Seminar June 9, 2009

Cancer. 2008 Aug 1;113(3):515-21.
Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Arico M, Ziino O, Valsecchi MG, Cazzaniga G, Baronci C, Messina C, Pession A, Santoro N, Basso G, Conter V; Italian Association of Pediatric Hematology and Oncology (AIEOP).

Morning Seminar June 4, 2009

Cancer. 2008 Mar 15;112(6):1345-53.
High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors.
Shih CS, Hale GA, Gronewold L, Tong X, Laningham FH, Gilger EA, Srivastava DK, Kun LE, Gajjar A, Fouladi M.

Morning Seminar June 2, 2009

Leukemia. 2009 May 14. [Epub ahead of print]
Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.
Cho BS, Lee S, Kim YJ, Chung NG, Eom KS, Kim HJ, Min CK, Cho SG, Kim DW, Lee JW, Min WS, Kim CC.

Blood. 2009 Mar 26;113(13):2902-5.
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.
Bachanova V, Verneris MR, DeFor T, Brunstein CG, Weisdorf DJ.

Morning Seminar May 28, 2009

Blood 2009;113:5083
Acute mixed lineage leukemia in children: The experience of St. Jude Children's Research Hospital.
Rubnitz JE, Onciu M, Pounds S, Shurtleff S, Cao X, Raimondi SC, Behm FG, Campana D, Razzouk BI, Ribeiro RC, Downing JR, Pui CH.

Morning Seminar May 26, 2009

Clin Infect Dis. 2004 Jul 1;39(1):31-7.
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL.

Morning Seminar May 21, 2009

J Clin Oncol. 2009 Mar 10;27(8):1304-9.
Early and late mortality after diagnosis of wilms tumor.
Cotton CA, Peterson S, Norkool PA, Takashima J, Grigoriev Y, Breslow NE.

Morning Seminar May 19, 2009

Pediatr Hematol Oncol. 2008 Dec;25(8):705-22.
Safety of hematopoietic stem cell transplantation in children less than three years of age.
Dvorak CC, Wright NB, Wong WB, Kristovich KM, Matthews EW, Weinberg KI, Amylon MD, Agarwal R.

Morning Seminar May 12, 2009

Leukemia. 2008 Apr;22(4):771-82.
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.
Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S, Stanulla M, Basso G, Niggli FK, Schäfer BW, Sutton R, Koehler R, Zimmermann M, Valsecchi MG, Gadner H, Masera G, Schrappe M, van Dongen JJ, Biondi A, Bartram CR; International BFM Study Group (I-BFM-SG).

Morning Seminar April 16, 2009

Bone Marrow Transplant. 2008 Jun;41 Suppl 2:S96-9.
Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives.
abusin M, Andolina M, Maximova N; EBMT Paediatric, Autoimmune Diseases Working Parties.

Morning Seminar April 14, 2009

Leukemia. 2007 Nov;21(11):2258-63.
Outcome of risk-based therapy for infant acute lymphoblastic leukemia with or without an MLL gene rearrangement, with emphasis on late effects: a final report of two consecutive studies, MLL96 and MLL98, of the Japan Infant Leukemia Study Group.
Tomizawa D, Koh K, Sato T, Kinukawa N, Morimoto A, Isoyama K, Kosaka Y, Oda T, Oda M, Hayashi Y, Eguchi M, Horibe K, Nakahata T, Mizutani S, Ishii E.

Blood. 2004 Dec 1;104(12):3527-34.
Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.
Kosaka Y, Koh K, Kinukawa N, Wakazono Y, Isoyama K, Oda T, Hayashi Y, Ohta S, Moritake H, Oda M, Nagatoshi Y, Kigasawa H, Ishida Y, Ohara A, Hanada R, Sako M, Sato T, Mizutani S, Horibe K, Ishii E.

Blood. 2006 Feb 1;107(3):1238-9.
KIR-incompatible hematopoietic-cell transplantation for poor prognosis infant acute lymphoblastic leukemia.
Triplett B, Handgretinger R, Pui CH, Leung W.